These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8292687

  • 1. Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
    Tancer ME, Stein MB, Uhde TW.
    Biol Psychiatry; 1993 Nov 01; 34(9):591-5. PubMed ID: 8292687
    [Abstract] [Full Text] [Related]

  • 2. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
    Tancer ME, Stein MB, Black B, Uhde TW.
    Am J Psychiatry; 1993 Feb 01; 150(2):336-7. PubMed ID: 8422091
    [Abstract] [Full Text] [Related]

  • 3. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Pharmacopsychiatry; 1995 May 01; 28(3):80-3. PubMed ID: 7568369
    [Abstract] [Full Text] [Related]

  • 4. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Rapaport MH, Risch SC, Gillin JC, Golshan S, Janowsky DS.
    Am J Psychiatry; 1989 Jan 01; 146(1):92-5. PubMed ID: 2492166
    [Abstract] [Full Text] [Related]

  • 5. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC.
    Biol Psychiatry; 1992 Jul 01; 32(1):18-25. PubMed ID: 1391293
    [Abstract] [Full Text] [Related]

  • 6. Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls.
    Tancer ME, Stein MB, Uhde TW.
    Anxiety; 1992 Jul 01; 1(3):138-40. PubMed ID: 9160563
    [No Abstract] [Full Text] [Related]

  • 7. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
    Brambilla F, Perna G, Garberi A, Nobile P, Bellodi L.
    Psychoneuroendocrinology; 1995 Jul 01; 20(1):1-9. PubMed ID: 7838898
    [Abstract] [Full Text] [Related]

  • 8. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD, Papp LA, Martinez J, Pine D, Rosenblum LA, Cooper T, Liebowitz MR, Gorman JM.
    Am J Psychiatry; 1995 Apr 01; 152(4):619-22. PubMed ID: 7694915
    [Abstract] [Full Text] [Related]

  • 9. Distinguishing panic disorder and agoraphobia from social phobia.
    Page AC.
    J Nerv Ment Dis; 1994 Nov 01; 182(11):611-7. PubMed ID: 7964668
    [Abstract] [Full Text] [Related]

  • 10. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls.
    van Vliet IM, Westenberg HG, Slaap BR, den Boer JA, Ho Pian KL.
    Biol Psychiatry; 1997 Jul 01; 42(1):76-8. PubMed ID: 9193745
    [No Abstract] [Full Text] [Related]

  • 11. Hyperventilation in panic disorder and social phobia.
    Nardi AE, Valença AM, Nascimento I, Mezzasalma MA, Zin WA.
    Psychopathology; 2001 Jul 01; 34(3):123-7. PubMed ID: 11316957
    [Abstract] [Full Text] [Related]

  • 12. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR.
    Acta Psychiatr Scand; 1992 Oct 01; 86(4):273-82. PubMed ID: 1333719
    [Abstract] [Full Text] [Related]

  • 13. Phenomenology and neurobiology of social phobia: comparison with panic disorder.
    Uhde TW, Tancer ME, Black B, Brown TM.
    J Clin Psychiatry; 1991 Nov 01; 52 Suppl():31-40. PubMed ID: 1757454
    [Abstract] [Full Text] [Related]

  • 14. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
    Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC.
    Arch Gen Psychiatry; 1991 Feb 01; 48(2):157-62. PubMed ID: 1989571
    [Abstract] [Full Text] [Related]

  • 15. Flumazenil challenge in social phobia.
    Coupland NJ, Bell C, Potokar JP, Dorkins E, Nutt DJ.
    Depress Anxiety; 2000 Feb 01; 11(1):27-30. PubMed ID: 10723632
    [Abstract] [Full Text] [Related]

  • 16. An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder.
    Gelernter CS, Stein MB, Tancer ME, Uhde TW.
    J Clin Psychiatry; 1992 Jan 01; 53(1):23-7. PubMed ID: 1737736
    [Abstract] [Full Text] [Related]

  • 17. The structure of phobias in panic disorder.
    Argyle N, Solyom C, Solyom L.
    Br J Psychiatry; 1991 Sep 01; 159():378-82. PubMed ID: 1958949
    [Abstract] [Full Text] [Related]

  • 18. A comparison of patients with illness phobia and panic disorder.
    Noyes R, Wesner RB, Fisher MM.
    Psychosomatics; 1992 Sep 01; 33(1):92-9. PubMed ID: 1539109
    [Abstract] [Full Text] [Related]

  • 19. [3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers.
    Stein MB, Delaney SM, Chartier MJ, Kroft CD, Hazen AL.
    Biol Psychiatry; 1995 Feb 15; 37(4):224-8. PubMed ID: 7711158
    [Abstract] [Full Text] [Related]

  • 20. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM.
    Neuropsychopharmacology; 1992 Feb 15; 6(2):101-18. PubMed ID: 1610485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.